Publications scientifiques

Poster presented at the Digital International Liver Congress – EASL – August 27-29, 2020 Hepatic fibrosis diagnosis is important for risk stratification, prognosis evaluation and monitoring of treatment response. Using computer tomography (CT) perfusion imaging and splenic radiomics, the objective of this study is to validate the use this non-invasive fibrosis scoring method to identify patients whose tumors are at high risk of recurrence after hepatic resection.
Elton Rexhepaj [1], Corinne Ramos [1], Yan Liu [1], Benoit Huet [1], Olivier Lucidarme [2], Nozha Boujemaa [1] – Affiliations: [1] Median Technologies, Valbonne, France – [2] Hôpital Universitaire Pitié-Salpêtrière-APHP, Paris, France

Poster presented at the ESMO Asia meeting – November 20-22, 2020 The poster presents results from a study dealing with inter-reader discrepancies in image-based oncology trials in BICR settings. Inter-reader discrepancy is a metric of choice for detecting quality issues in clinical trials. The study provides reference values metrics to monitor reader performance with double read plus adjudication in clinical trials using RECIST 1.1.
Hubert Beaumont [1], Antoine Iannessi [1], Jennifer Cillario [1], Yan Liu [1] – Affiliations: [1] Median Technologies, Valbonne, France

Poster presented at The Liver Meeting, organized by the American Association for the Study of Liver Diseases, Nov 13-16, 2020 – Virtual experience Based on a meta-analysis, the poster analyses radiomics contribution to liver cancer recurrence prediction and shows how radiomics are approaching their limits for predicting disease outcome.  Imaging phenomics, an emerging technology implemented in Median’s iBiopsy® platform may provide the framework to explore new associations between phenotypes which are currently not feasible using traditional radiomic workflows.
Yan Liu [1] [2] , Elton Rexhepaj [3] , Afef Baili Laya [3] , Corinne Ramos [3] , Hubert Beaumont [1] , Nozha Boujemaa [3] , Anthony Lockett [2] – Affiliations [1] Medical Affairs, Median Technologies, Valbonne, France, [2] Bioscience , King’s College London, London, UK – [3] iBiopsy® Business Unit, Median Technologies, Valbonne, France

Poster presented at the ESMO 2020 Virtual Congress | September 17, 2020 |Poster Display Session 1936P For tumor response assessment in oncology trials with radiology, the baseline (BL) evaluation is critical as the selection of target lesions (TL) determines the quality of follow-up. The RECIST workgroup provided a method and recommendations for: 1) selecting TL and non-target lesions (NTL) for reporting disease evolution, 2) choosing up to 5 targets, with a maximum of two per organs. In the practice, the selection of TL is subjective; non-malignant (NM) lesions might be mistaken as TLs. The objectives of the study are 1) to analyze the impact of selecting non-malignant lesions as target lesions at baseline, and 2) to present recommendations to mitigate risks in clinical trials.
Antoine Iannessi [1], Hubert Beaumont [1], Yan Liu [1], Anne Sophie Bertrand [2] – Affiliations: [1] Median Technologies, Valbonne, France, [2] Polyclinique Les Fleurs, 83190 Ollioules, France

Poster presented at the IEEE International Symposium on Biomedical Imaging (ISBI) | April 3-7, 2020 | Virtual conference. Segmentation of the different body structures on CT and MRI scans remains a challenging problem that requires accurate ground truth (GT) segmentation. One of the important aspects is the lack of reliability caused by radiologists annotation disagreement coupled with insufficient quality of the medical images. An independent multiple annotation is needed to overcome frequent disagreements between radiologists decisions mostly on the organs border, which is always blurred and affects on the providing an accurate segmentaKon even on contrasted CT/MRI images. Augmentation techniques aim at increasing model generalization by manipulating inputs in order to enrich set of the variability of images in regards to their GT. We introduce a method to regularize the models learning process by augmenting the information only in the associated GT masks.
Vladimir Groza [1], Benoit Huet [1], Nozha Boujemaa [1] – Affiliations : [1] Median Technologies, Valbonne, France